Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

A community engagement framework to accelerate the uptake of malaria vaccines in Africa

Nature Medicine volume 30, pages 2706–2707 (2024)Cite this article

Subjects

Following the approval by the World Health Organization (WHO) of two new vaccines, RTS,S/AS01 and R21/Matrix-M, for malaria prevention in children, they are being administered in 12 malaria-endemic African countries, prioritizing areas with moderate to high transmission. These vaccines will be a game changer in the efforts to attain global elimination of malaria in the 35 or more malaria-endemic countries and achieve the Sustainable Development Goal of a 90% reduction in malaria incidence and mortality by 20301. The vaccines are expected to prevent half a million child deaths annually. Addressing the cost and production limitation of the prior malaria vaccine (RTS,S/AS01), the new R21/Matrix-M vaccine will be mass produced and delivered at an affordable, minimal cost2. These new vaccines come at a critical moment when malaria prevention and control programs are challenged by the impacts of climate change, the emergence of insecticide and drug-resistant strains, and new variants of mosquitos, particularly in urban areas.

An additional challenge in Africa is vaccine hesitancy, which has been seen for other new vaccines, including against COVID-19. The COVID-19 vaccines activated widespread dissemination of vaccine conspiracies and misinformation3. Consequently, the general public have questioned the safety and quality of vaccines. For example, in Cameroon, the COVID-19 pandemic led to a substantial drop in pediatric attendance for routine childhood immunizations between 2020 and 2022, and these numbers have not yet returned to pre-pandemic levels4. In some cases, vaccinators have been targeted and attacked due to misinformation and conspiracies against vaccines, including the killing of polio vaccination workers in Afghanistan, Pakistan and Nigeria, with the attackers alleging that the vaccines are administered to sterilize Muslims5,6,7. This disinformation can quickly spread through communities, including via social media.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. United Nations. Goal 10: Reduce inequality within and among countries. https://go.nature.com/3Yqs0lh (2015).

  2. World Health Organization. Malaria vaccines (RTS,S and R21). https://go.nature.com/3X0IVcR (2023).

  3. Regazzi, L., Lontano, A., Cadeddu, C., Di Padova, P. & Rosano, A. Eur. J. Public Health 33, 717–724 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  4. Chelo, D. et al. Arch. Pédiatrie 28, 441–450 (2021).

    Article  CAS  Google Scholar 

  5. Cousins, S. Lancet 397, 84–85 (2021).

    Article  CAS  PubMed  Google Scholar 

  6. Arie, S. BMJ 346, f954 (2013).

    Article  PubMed  Google Scholar 

  7. Wahid, B., Kumari, B., Saifullah, K. M. & Idrees, M. Asia Pac. J. Public Health 35, 183–188 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  8. Sulaiman, S. K. et al. PLoS ONE 17, e0278224 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chutiyami, M. et al. Infection https://doi.org/10.1007/s15010-024-02196-y (2024).

    Article  PubMed  Google Scholar 

  10. Datoo, M. S. et al. Lancet 403, 533–544 (2024).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Africa Centres for Disease Control and Prevention https://africacdc.org/

    Nebiyu Dereje, Mosoka Papa Fallah, Nicaise Ndembi, Alemayehu Duga, Tamrat Shaweno, Merawi Aragaw, Mohammed Abdulaziz, Ngashi Ngongo, Tajudeen Raji & Jean Kaseya

Authors
  1. Nebiyu Dereje
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mosoka Papa Fallah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nicaise Ndembi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alemayehu Duga
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tamrat Shaweno
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Merawi Aragaw
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mohammed Abdulaziz
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ngashi Ngongo
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tajudeen Raji
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Jean Kaseya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nebiyu Dereje.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dereje, N., Fallah, M.P., Ndembi, N. et al. A community engagement framework to accelerate the uptake of malaria vaccines in Africa. Nat Med 30, 2706–2707 (2024). https://doi.org/10.1038/s41591-024-03193-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-024-03193-2

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing